Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
http://www.nature.com/articles/pcan201124.pdf
Reference107 articles.
1. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277–300.
2. Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
3. Matsunaga N, Kaku T, Ojida A, Tanaka T, Hara T, Yamaoka M et al. C(17,20)-lyase inhibitors: design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C(17,20)-lyase inhibitors. Bioorg Med Chem 2004; 12: 4313–4336.
4. Vasaitis TS, Bruno RD, Njar VC . CYP17 inhibitors for prostate cancer therapy. J Steroid Biochem Mol Biol 2010; e-pub ahead of print.
5. Dreicer R, Agus DB, MacVicar GR, Wang J, MacLean D, Stadler WM . Safety, pharmacokinetics, and efficacy of TAK-700 in metastatic castration-resistant prostate cancer: a phase I/II, open-label study. J Clin Oncol 2010; 28 (Suppl): abstract 3084.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells;International Journal of Molecular Sciences;2022-12-03
2. Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness;Urologic Clinics of North America;2021-08
3. Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer;Hormones;2020-11-02
4. Angiogenesis Inhibition in Prostate Cancer: An Update;Cancers;2020-08-23
5. Quantification of 2-aminoisobutyric acid impurity in enzalutamide bulk drug substance using hydrophilic interaction chromatography with fluorescence detection;Journal of Pharmaceutical and Biomedical Analysis;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3